DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Sai Parenterals Limited — Outcome of Board Meeting

NSE 3 hrs ago·11 Aug 2026, 12:45 pm

SAIPARENT NSE

Sai Parenterals Limited has informed the stock exchange that its board has approved the financial results for the period ending June 30, 2026. This announcement confirms that the company has completed its internal review and reporting process for the specified quarter.

For investors, this update is a routine but necessary step in the corporate disclosure process. It provides a formal confirmation of the company's financial standing, allowing shareholders to track performance against previous periods and market expectations.

Investors should watch for the detailed financial statements to be released shortly. This data will offer deeper insights into the company's operational efficiency and overall profitability, which are key factors in evaluating the stock's future potential.